Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailored Treatment to Enhance Risk Perception in Sleep Apnea.

NCT02314858 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT02314858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02314858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailored Treatment to Enhance Risk Perception in Sleep Apnea.
Lead sponsor
National Jewish Health
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2014
Completion date
March 31, 2021
Enrollment
284 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea (osa)